Inpharmation Limited
03567687
Healthy
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 22/05/1998
DEPUTY CHAIRMAN
BRITISH · UNITED KINGDOM · Age 67
Also on 5 other boards
secretary · Since 22/05/1998
COMPANY DIRECTOR
BRITISH · UNITED KINGDOM · Age 67
Also on 5 other boards
director · Since 01/04/2003
DIRECTOR OF PROGRAMMING
BRITISH · ENGLAND · Age 68
Also on 1 other board
Persons with Significant Control
Mrs Karen Johnson
British · United Kingdom · Age 67
Evidence House, Stokenchurch Business Park, Stokenchurch, HP14 3FE
Notified 04/11/2025
Mr Gary Anthony Johnson
British · United Kingdom · Age 67
Evidence House, Stokenchurch Business Park, Stokenchurch, HP14 3FE
Notified 04/11/2025
Former PSCs
Mr Gary Anthony Johnson
Ceased 04/11/2025
Mrs Karen Johnson
Ceased 04/11/2025
CompanyRankvs 77+ SIC 62012 peers90
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£5.4M
Balance sheet strength
Cash
£3.7M
Cash in the bank
Net Current Assets
£3.5M
Working capital
Current Assets
£4.4M
Current Liabilities
£841k
Fixed Assets
£1.9M
Debtors
£680k
Tax at Year End
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit | Est. Revenue |
|---|---|---|---|
| 2025 | 5.18 | -£1.1M | £448k |
| 2024 | 7.48 | +£311k | £432k |
| 2023 | 5.46 | +£1.2M | £323k |
| 2022 | 4.65 | -£1.5M | — |
| 2021 | 6.62 | -£840k | — |
| 2020 | 6.99 | +£1.9M | — |
| 2019 | 5.15 | +£1.4M | — |
| 2017 | 6.58 | — | — |
Derived from filed accounts. Not audited figures.